Motus GI Holdings, Inc. (MOTS)
OTCMKTS: MOTS · Delayed Price · USD
0.0600
+0.0100 (20.00%)
Jul 22, 2024, 9:30 AM EDT - Market open
Motus GI Holdings Market Cap
Motus GI Holdings has a market cap or net worth of $383.33 thousand as of July 22, 2024. Its market cap has decreased by -91.09% in one year.
Market Cap
383.33K
Enterprise Value
-2.19M
1-Year Change
-91.09%
Ranking
n/a
Category
Stock Price
$0.06
Market Cap Chart
Since February 14, 2018, Motus GI Holdings's market cap has decreased from $68.20M to $383.33K, a decrease of -99.44%. That is a compound annual growth rate of -56.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2024 | 900.00K | 28.57% |
| Dec 29, 2023 | 700.00K | -82.05% |
| Dec 30, 2022 | 3.90M | -82.67% |
| Dec 31, 2021 | 22.50M | -26.47% |
| Dec 31, 2020 | 30.60M | -53.57% |
| Dec 31, 2019 | 65.90M | 35.04% |
| Dec 31, 2018 | 48.80M | -28.45% |
| Feb 14, 2018 | 68.20M | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 814.94B |
| Novo Nordisk | 579.91B |
| UnitedHealth Group | 520.32B |
| Johnson & Johnson | 372.29B |
| Merck & Co. | 318.55B |
| AbbVie | 304.29B |
| AstraZeneca | 244.04B |
| Novartis AG | 207.64B |